← All organizations
Highest phase reached
Phase 3
First clinical trial
May 11, 2020Last known activity
Sep 11, 2025
Timeline
2010s
- Jun 1, 2014
SystImmune Inc.— Founded
Drugs by trial phase (18 distinct, 26 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (30)
- NCT06926868CollaboratorPhase 2/Phase 3Sep 11, 2025
- NCT07021066Lead sponsorPhase 1Jul 30, 2025
- NCT07021066OfficialPhase 1Jul 30, 2025
- NCT07080242OfficialPhase 1Apr 28, 2025
- NCT07080242Lead sponsorPhase 1Apr 28, 2025
- NCT06714617Lead sponsorPhase 1Mar 1, 2025
- NCT06714591Lead sponsorPhase 1Dec 31, 2024
- NCT06293898OfficialPhase 1Feb 9, 2024
- NCT06293898Lead sponsorPhase 1Feb 9, 2024
- NCT05983432Study directorPhase 1Aug 8, 2023
- NCT05983432Lead sponsorPhase 1Aug 8, 2023
- NCT05623982CollaboratorPhase 1/Phase 2Dec 31, 2022
- NCT05631964CollaboratorPhase 1Dec 31, 2022
- NCT05627856CollaboratorPhase 1/Phase 2Nov 30, 2022
- NCT05470348CollaboratorPhase 1Aug 11, 2022
Details
- Founded
- Richmond, WA, US Jun 1, 2014
- Last known activity
- Sep 11, 2025